How Clinical Trials Can Improve eClinical Data Integrity System...

Pharma Tech Outlook: Pharma Tech Magazine

How Clinical Trials Can Improve eClinical Data Integrity System Efficiency

By Pharma Tech Outlook | Friday, December 04, 2020

Risk management is an essential part of the eClinical data integrity system because there are many risks in the clinical trial's data lifecycle.

FREMONT, CA: Data integrity security has become more crucial across clinical trials in the last few years. Agencies like the FDA and MHRA continuously stress the importance of data integrity in clinical trials. Today data integrity is immensely impacting the eClinical technologies as it prioritized IRT and eCOA. Here are some of the common problems and effective preventive actions that can be put in place on the IT infrastructure, study level, and platform.

Risk Management in the Digital Age

The regulators worldwide are increasing the influence to increase the strength of their data integrity practices. Furthermore, adequate risk mitigation and management are essential for data integrity because there are many risk points through the clinical trial's data lifecycle. The capture of endpoint data through storage, reporting, data recording, and transfer, the eClinical system introduces risk to data integrity. It can be controlled by documenting eClinical data procedures and by making them transparent and traceable via audit trials.

One of the best ways clinical trials can ensure that things do not go wrong is by anticipating these difficulties before building their eClinical systems and developing strategies to solve them. The system can also help manage risk when the design integrates tools that indicate risk for every function and how the risks can impact patient safety and data integrity.

The critical tried and accurate components will always consist of quality systems, continuous user support, and robust training. Others can be more fluid and need regular evaluation and modification because the digital age paradigm continuously shifts and eCOA continually develop. There are also various extra considerations, which go hand in hand with the increasing dependency on eSource data and the electronic systems that the clinical trials apply and pull from continuing to expand. It is the most significant factor when eCOA data are utilized for supporting significant endpoints. 

Here are some of the essential factors to consider while developing a risk management plan.

• Web backup solutions

• Compliance strategies

• Data integrity plans

• Data transparency and audit trials

• Cybersecurity

• Data standardization


Check This Out: Top Pharma and Life Sciences Tech Solution Companies

Weekly Brief

Read Also